Literature DB >> 9430232

Genetic control of diabetes progression.

A Gonzalez1, J D Katz, M G Mattei, H Kikutani, C Benoist, D Mathis.   

Abstract

Autoimmune diabetes in both the human and the nonobese diabetic mouse has elaborate genetics; in the latter case, the disease is influenced by at least 15-20 loci. We anticipated that the genetics would be simpler in the BDC2.5 T cell receptor transgenic mouse model of diabetes, wherein many T cells express a particular diabetogenic specificity. Initiation of insulitis in this model was the same on the two genetic backgrounds analyzed, but the kinetics and penetrance of diabetes were strikingly different, permitting us to focus on genetic influences during a defined window of disease progression. The differences correlated with variations in five genomic intervals, certain ones of which have been previously implicated in susceptibility to autoimmune disease. This reductionist approach indeed simplified the analysis of diabetes susceptibility loci.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430232     DOI: 10.1016/s1074-7613(00)80405-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  50 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus.

Authors:  J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 3.  Genetic analysis of type 1 diabetes: embryonic stem cells as new tools to unlock biological mechanisms in type 1 diabetes.

Authors:  Nick Holmes; Anne Cooke
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration.

Authors:  SuFey Ong; Davinna L Ligons; Jobert G Barin; Lei Wu; Monica V Talor; Nicola Diny; Jillian A Fontes; Elizabeth Gebremariam; David A Kass; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2015-01-23       Impact factor: 4.307

5.  Singular role for T-BET+CXCR3+ regulatory T cells in protection from autoimmune diabetes.

Authors:  Tze Guan Tan; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

6.  Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.

Authors:  Markus Feuerer; Wenyu Jiang; Phillip D Holler; Ansuman Satpathy; Christopher Campbell; Molly Bogue; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

7.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

Authors:  Thomas Stratmann; Natalia Martin-Orozco; Valérie Mallet-Designe; Laurent Poirot; Dorian McGavern; Grigoriy Losyev; Cathleen M Dobbs; Michael B A Oldstone; Kenji Yoshida; Hitoshi Kikutani; Diane Mathis; Christophe Benoist; Kathryn Haskins; Luc Teyton
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

8.  Defective positive selection results in T cell lymphopenia and increased autoimmune diabetes in ADAP-deficient BDC2.5-C57BL/6 mice.

Authors:  Liangxing Zou; Felipe Mendez; Natalia Martin-Orozco; Erik J Peterson
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

9.  The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.

Authors:  Maximiliano Presa; Yi-Guang Chen; Alexandra E Grier; Edward H Leiter; Michael A Brehm; Dale L Greiner; Leonard D Shultz; David V Serreze
Journal:  J Immunol       Date:  2015-08-17       Impact factor: 5.422

10.  Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity.

Authors:  Laurent Poirot; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.